Plasmodium vinckei:Optimization of Desferrioxamine B Delivery in the Treatment of Murine Malaria
- 31 July 1998
- journal article
- Published by Elsevier in Experimental Parasitology
- Vol. 89 (3) , 323-330
- https://doi.org/10.1006/expr.1998.4282
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Iron and InfectionActa Clinica Belgica, 1996
- Results of Long-Term Iron-Chelating TherapyActa Haematologica, 1996
- Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophoresAntimicrobial Agents and Chemotherapy, 1995
- The transport of two iron chelators, desferrioxamine B and L1, across Caco‐2 monolayersBritish Journal of Haematology, 1994
- Effect of Iron Chelation Therapy on Recovery from Deep Coma in Children with Cerebral MalariaNew England Journal of Medicine, 1992
- Plasmodicidal effect of desferrioxamine B in human vivax or falciparum malaria from ThailandActa Tropica, 1992
- Deferoxamine inhibition of malaria is independent of host iron status.The Journal of Experimental Medicine, 1988
- RECENT TRENDS IN THE EPIDEMIOLOGY AND CONTROL OF MALARIA1Epidemiologic Reviews, 1987
- Plasmodium vinckei: Suppression of mouse infections with desferrioxamine BExperimental Parasitology, 1985
- Pharmacokinetics of the iron chelator desferrioxamine as affected by liposome encapsulation: Potential in treatment of chronic hemosiderosisLife Sciences, 1978